Editorial: Innate and adaptive immunity against tuberculosis infection: diagnostics, vaccines, and therapeutics

Zhidong Hu; Lanbo Shi; Jianping Xie; Xiao-Yong Fan

doi:10.3389/fimmu.2024.1366976

Editorial: Innate and adaptive immunity against tuberculosis infection: diagnostics, vaccines, and therapeutics

Front Immunol. 2024 Jan 23:15:1366976. doi: 10.3389/fimmu.2024.1366976. eCollection 2024.

Authors

Zhidong Hu¹, Lanbo Shi², Jianping Xie³, Xiao-Yong Fan¹

Affiliations

¹ Shanghai Public Health Clinical Center & Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.
² Public Health Research Institute, New Jersey Medical School, Rutgers Biomedical and Health Sciences, Rutgers, The State University of New Jersey, Newark, NJ, United States.
³ Chongqing Municipal Key Laboratory of Karst Environment, School of Life Sciences, Southwest University, Chongqing, China.

No abstract available

Keywords: adaptive immunity; diagnostics; innate immunity; therapeutics; tuberculosis; vaccines.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Adaptive Immunity
Humans
Latent Tuberculosis*
Tuberculosis*
Vaccines*

Substances

Vaccines

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. National Natural and Science Foundation of China (82171739, 82171815, 32394014), National Key Research and Development Program of China (2021YFC2301503, 2022YFC2302900), and Shanghai Municipal Health Bureau (2022XD060).